← All brands
Slate Run Pharmaceuticals
1 recall
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-03-04 | FDA Drug | FDA Recall: Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Via | Slate Run Pharmaceuticals | Class III | N/A |